Jeffrey Arnold

I am the president of Arnold Strategies, LLC, a strategic advisor to early and growth stage CEO's, an angel investor with Mass. Med. Angels and Boston Harbor Angels and part-time executive chairman of First Light Biosciences.

Prior to founding Arnold Strategies, I spent 20 years as the CEO of multiple private and public technology and life science companies. Among these are Cambridge Heart, a cardiology diagnostics company I founded and took public, CardioFocus, a VC backed catheter ablation company and Accelrys, with software tools for rational drug design, now a division of Dassault Systemes.

Angel investments have included, among others, SmartCells (sold to Merck), BioAssets development Corp (sold to Cephalon), Syntonix (sold to Biogen Idec), Health Honors (sold to Healthway) and JB Therapeutics (now public as Corbus Pharmaceuticals).

Also a guest lecturer at the MIT Sloan School, member of the MIT Venture Mentoring Society, on the Grant Review Board of the MIT Deshpande Center and on the board of overseers at the Museum of Science. Received a BSEE from MIT in 1972.

See www.arnoldstrategies.com